Manufacturing: Page 33
-
Pfizer to invest $100M in build-out of gene therapy site
Pfizer acquired the Sanford, NC-based facility as part of its $645 million acquisition of Bamboo Therapeutics last year.
By Suzanne Elvidge • Aug. 10, 2017 -
Manufacturing issues threaten delay for Aerie eye drug
But Aerie believes the issues at its third party manufacturer's facility will be resolved before the expected decision date for its glaucoma med Rhopressa.
By Ned Pagliarulo • Aug. 10, 2017 -
Opioid drugmakers may have to slash production under new DEA proposal
The agency is mulling a 20% reduction in the manufacturing of the Schedule II drugs for 2018.
By Jacob Bell • Aug. 9, 2017 -
Sponsored by Bioclinica
Accelerate your database lock using Clean Patient Optics
Using the powerful data visualization tools in Clean Patient Optics, study teams can uncover patterns about the status of patient data external to the EDC system for early identification of potential study problems.
Aug. 8, 2017 -
Closing Claris deal, Baxter set to invest in three new plants
Baxter expects the injectable drugmaker will bring it $55 million worth of incremental sales during 2017.
By Jacob Bell • Aug. 3, 2017 -
Embattled Teva slashes staff, manufacturing facilities
Lower-than-expected revenues in the second quarter, due to greater pressure on generics, is pushing the Israeli company to look at cost-cutting measures.
By Lisa LaMotta • Aug. 3, 2017 -
Seattle Genetics brings manufacturing in-house
In a $43 million deal, the Washington biotech bought a plant from Bristol-Myers Squibb, giving it more control of its supply chain.
By Suzanne Elvidge • Aug. 3, 2017 -
LabCorp strengthens its CRO standing with $1.2B Chiltern acquisition
The deal should expand the buyer's CRO workforce to more than 11,000 employees.
By Jacob Bell • July 31, 2017 -
Novartis taps Cryoport for CAR-T logistics support
The Swiss pharma is gearing up for an expected approval of its landmark leukemia treatment later this year, inking deals ahead of time to manage the complex manufacturing and supply chain requirements.
By Ned Pagliarulo • July 27, 2017 -
Tesaro lands licensing, supply agreements for Zejula
Two separate deals have Takeda handing over $100 million upfront for rights to the cancer med and STA Pharmaceutical providing the materials to make it.
By Jacob Bell • July 27, 2017 -
Corning invests $500M to build better glass packaging for pharma
Big drugmakers Merck and Pfizer have already expressed interest in using the Valor Glass product.
By Ned Pagliarulo • July 27, 2017 -
Endo closes plant, cuts hundreds of jobs
The Irish pharma is closing a plant in Alabama due to lower demand, a move that will lead to the loss of several hundred jobs.
By Lisa LaMotta • July 27, 2017 -
Boehringer to invest $217M in manufacturing build-out at CA site
The German drugmaker's upgrade and expansion to its biologics facility in Fremont will add almost 300 new jobs.
By Suzanne Elvidge • July 26, 2017 -
GSK to ax hundreds of jobs through manufacturing shuffle
The big pharma plans to outsource some of the work at its facility in Worthing, as well as sell off the Horlicks brand of malted milk drinks in the U.K.
By Jacob Bell • July 20, 2017 -
Case study: How a trade deal will affect pharma R&D, supply chains
Canada's recent drug patent reform shows how modern trade deals go beyond tariff reduction to push for regulatory changes that benefit certain industries.
By Edwin Lopez • July 20, 2017 -
Novartis touts manufacturing efforts after restructuring
Everything from R&D to production has benefited from the Swiss pharma reconfiguring its organization last year.
By Lisa LaMotta • July 20, 2017 -
BiondVax grows vaccine production with new facility
The Israeli drugmaker plans to use the nearly 20,000-square-foot space to manufacture its experimental universal flu vaccine.
By Jacob Bell • July 19, 2017 -
Amid supply shortage, FDA clears import of in-demand drug
Athenex, Inc. will be allowed to import sodium bicarbonate 8.4% injection from an Australian manufacturer as supply of the critical drug continues to run dry.
By Ned Pagliarulo • July 13, 2017 -
German Merck axes 200 jobs in production consolidation
In a drive towards efficiency, Merck KGaA is shuffling sites in Europe.
By Suzanne Elvidge • July 13, 2017 -
Vistin hands partner its opioid, CMO businesses
The move will make the Norwegian drugmaker a pure-play developer of metformin for diabetes treatment.
By Jacob Bell • July 13, 2017 -
Manufacturing problems once again stall Ocular's Dextenza
The eye drug developer received another complete response letter for its post-surgical pain treatment.
By Jacob Bell • July 12, 2017 -
Novo Nordisk recalls six batches of insulin cartridge holders
Affected holders could crack or break when exposed to certain chemicals, leading to delivery of lower insulin doses, the Danish drugmaker said.
By Ned Pagliarulo • July 6, 2017 -
GSK taps suppliers, Schneider to meet emission targets
The British drugmaker aims to be carbon neutral by 2050 and will need help from its hundreds of suppliers to help cut down on emissions.
By Edwin Lopez • July 6, 2017 -
FDA issues warning letter to Chinese heparin maker
The agency cited issues with the system suitability and data controls — among other things — at the Shandong Analysis and Test Center.
By Jacob Bell • July 6, 2017 -
Oxford BioMedica, Novartis link up on CAR-T drug production
The deal could provide more than $100 million to the U.K.-based gene therapy developer as well as long-term profitability, according to analysts.
By Jacob Bell • July 6, 2017
Previous
